Cerebrospinal fluid levels of calcium, magnesium, copper and zinc in patients with Alzheimer's disease and mild cognitive impairment

Trace Elements and Electrolytes

Volumn 23, Issue 4, 2006, Pages 247-250

  Kovatsi, L ^a,c   Touliou, K ^b   Tsolaki, M ^b   Kazis, A ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b G Papanikolaou Hospital   (Greece)

^c NONE   (Greece)

Author keywords

Alzheimer's disease; Calcium; Copper; Magnesium; Zinc

Indexed keywords

CALCIUM; COPPER; MAGNESIUM; ZINC;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL;

EID: 33750385455     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep23247     Document Type: Article

References (12)

1. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem. 1998; 273: 12817-12826.
2. Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect. 1991; 3: 231-258.
3. Fountoulakis KN, Tsolaki M, Iacovides A, Yesavage J, O' Hara R, Kazis A, Ierodiaconou CH. The validation of the short form of Geriatric Depression Scale in Greece. Aging Clin Exp Res. 1999; 11: 367-372.
4. Fountoulakis KN, Tsolaki M, Chatzi E, Kazis A. Mini Mental State Examination (MMSE). Validation in Greek elderly patients with dementia. Am J Alz Dis. 2000; 15: 342-347.
5. Glick JL. Dementias: the role of magnesium deficiency and an hypothesis concerning the pathogenesis of Alzheimer's disease. Med Hypotheses. 1990; 31: 211-225.
6. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987; 325: 733-736.
7. Lynch T, Cherny RA, Bush AI. Oxidative process in Alzheimer's disease. The role of abeta-metal interactions. Exp Gerontol. 2000; 35: 445-451.
8. Maury CP. Molecular pathogenesis of beta-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Lab Invest. 1995; 72: 4-16.
9. Moir RD, Atwood CS, Romano DM, Laurans MH, Huang X, Bush AI, Smith JD, Tanzi RE. Differential effects in apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations. Biochem. 1999; 38: 4595-4603.
10. Molina JA, Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzlez-Munoz MJ, De Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm. 1998; 105: 479-488.
11. Subhash MN, Padmashree TS, Srinivas KN, Subbakrishna DK, Shankar SK. Calcium and phosphorus levels in serum and CSF in dementia. Neurobiol Aging. 1991; 12: 267-269.
12. Tsolaki M, Fountoulakis K, Chanzi E, Kazis A. The Cambridge Cognitive Examination for the elderly (CAMCOG). A validation study in demented patients from the elderly Greek population. Am J Alz Dis. 2000; 15: 269-278.